112 related articles for article (PubMed ID: 21106442)
1. The devil's advocacy: when and why inhaled therapies for tuberculosis may not work.
Yadav AB; Singh AK; Verma RK; Mohan M; Agrawal AK; Misra A
Tuberculosis (Edinb); 2011 Jan; 91(1):65-6. PubMed ID: 21106442
[TBL] [Abstract][Full Text] [Related]
2. Inhaled drug therapy for treatment of tuberculosis.
Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models.
Liang Y; Wang X; Song J; Wang L; Chen D; Yang Y; Bai X; Wang J; Shi Y; Chen S; Liu J; Yang C; Luo H; Liu G; Wu X
J Ethnopharmacol; 2017 Jan; 195():318-323. PubMed ID: 27884716
[TBL] [Abstract][Full Text] [Related]
4. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
[TBL] [Abstract][Full Text] [Related]
5. The long and winding road to inhaled TB therapy: not only the bug's fault.
Giovagnoli S; Schoubben A; Ricci M
Drug Dev Ind Pharm; 2017 Mar; 43(3):347-363. PubMed ID: 27977937
[TBL] [Abstract][Full Text] [Related]
6. Some healthy skepticism about inhaled therapy for tuberculosis.
Iseman MD
Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
[No Abstract] [Full Text] [Related]
7. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of the tuberculous lung: considerations for inhaled therapies.
Sethi T; Agrawal A
Tuberculosis (Edinb); 2011 Jan; 91(1):67-70. PubMed ID: 20947432
[TBL] [Abstract][Full Text] [Related]
9. Optimization of inhaled therapies for tuberculosis: the role of macrophages and dendritic cells.
González-Juarrero M; O'Sullivan MP
Tuberculosis (Edinb); 2011 Jan; 91(1):86-92. PubMed ID: 20888298
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized gentamicin reduces the burden of tuberculosis in a murine model.
Roy CJ; Sivasubramani SK; Dutta NK; Mehra S; Golden NA; Killeen S; Talton JD; Hammoud BE; Didier PJ; Kaushal D
Antimicrob Agents Chemother; 2012 Feb; 56(2):883-6. PubMed ID: 22143521
[TBL] [Abstract][Full Text] [Related]
11. Would you know one if you met one?
Grange JM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1162-3. PubMed ID: 11769777
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
13. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
14. Aerosol vaccines for tuberculosis: a fine line between protection and pathology.
Hokey DA; Misra A
Tuberculosis (Edinb); 2011 Jan; 91(1):82-5. PubMed ID: 21067975
[TBL] [Abstract][Full Text] [Related]
15. [Results of polychemotherapy in patients with newly detected destructive pulmonary tuberculosis].
Berezovskiĭ BA; Popova II; Pshevorskiĭ VIa
Probl Tuberk; 1990; (4):50-2. PubMed ID: 2118644
[TBL] [Abstract][Full Text] [Related]
16. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
Veen J
Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
[No Abstract] [Full Text] [Related]
17. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
Ooizumi K
Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
[No Abstract] [Full Text] [Related]
18. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
[TBL] [Abstract][Full Text] [Related]
20. Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb.
Lawlor C; Kelly C; O'Leary S; O'Sullivan MP; Gallagher PJ; Keane J; Cryan SA
Tuberculosis (Edinb); 2011 Jan; 91(1):93-7. PubMed ID: 21237714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
